Hepatocellular Carcinoma Treatment With Sorafenib: Real-Life Evaluation of Prognostic Factors and a Practical Clue for Patient Management

INTRODUCTION: Sorafenib chemotherapy is the first-line therapy for patients with hepatocellular carcinoma (HCC) in an advanced stage. The aim of this study was to evaluate prognostic factors of survival in HCC patients treated with sorafenib, in real-life clinical practice. MATERIAL AND METHODS: Ret...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:GE Port J Gastroenterol
Main Authors: Cardoso, Helder, Alves, Ana Margarida, Marques, Margarida, Vale, Ana Maria, Pereira, Pedro, Macedo, Guilherme
Formato: Artigo
Idioma:Inglês
Publicado em: Karger Publishers 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580019/
https://ncbi.nlm.nih.gov/pubmed/28868469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpge.2016.04.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados